Robin E. Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robin E. Clark has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Robert E. Drake
4 shared publicationsDeborah R. Becker
Departments of Community and Family Medicine and of Psychiatry, New Hampshire–Dartmouth Psychiatric Research Center and Dartmouth Medical School, Hanover, NH, USA
2 shared publicationsHaiyi Xie
Departments of Community and Family Medicine and of Psychiatry, New Hampshire–Dartmouth Psychiatric Research Center and Dartmouth Medical School, Hanover, NH, USA
2 shared publicationsAndrew Shaner
1 shared publicationBradley J. Dain
Departments of Community and Family Medicine and of Psychiatry, New Hampshire–Dartmouth Psychiatric Research Center and Dartmouth Medical School, Hanover, NH, USA
1 shared publicationDavid Lynde
1 shared publication
Latest Publications
- 15 November 2004
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 65 (11) , 1577-1578
Reply to "Prescribing Benzodiazepines for Patients With Substance Use Disorders"
- 15 November 2004
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 65 (11) , 1577-1578
Reply to "Prescribing Benzodiazepines for Patients With Substance Use Disorders"
- 1 January 2004
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 2 (1) , 102-110
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
- 1 January 2004
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 2 (1) , 102-110
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
- Open Access
- 1 January 2002
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 28 (1) , 75-84
Recent Trends in Antipsychotic Combination Therapy of Schizophrenia and Schizoaffective Disorder: Implications for State Mental Health Policy
Little is known about antipsychotic combination therapy, although this practice is becoming increasingly common in the treatment of schizophrenia. Medicaid pharmaceutical claims for a cohort of 836 New Hampshire beneficiaries with schizophrenia or schizoaffective disorder were followed from 1995 through 1999. Use of traditional and atypical antipsychotic medications, antidepressants, anxiolytic hypnotics, and mood stabilizers was tracked monthly. The number of medications, frequency of coprescription, and Medicaid pharmaceutical costs are described. The proportion of individuals with schizophrenia and schizoaffective disorder treated with atypical antipsychotics grew from 43 percent in 1995 to 70 percent in 1999. At the same time, concurrent use of two or more antipsychotic medications quadrupled, increasing from 5.7 percent to 24.3 percent. Persons with schizophrenia were also prescribed more antidepressants (increased from 18.5% in 1995 to 35.6% in 1999), anxiolytics (increased from 19.9% to 33.5%), and mood stabilizers (increased from 17.7% to 30.0%). The increase in multiple agent therapy appears to be broad-based. Data are needed on the effectiveness and cost-effectiveness of these practices to inform clinical decision making and health policy.
- 1 January 2002
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 28 (1) , 75-84
Open AccessRecent Trends in Antipsychotic Combination Therapy of Schizophrenia and Schizoaffective Disorder: Implications for State Mental Health Policy
Little is known about antipsychotic combination therapy, although this practice is becoming increasingly common in the treatment of schizophrenia. Medicaid pharmaceutical claims for a cohort of 836 New Hampshire beneficiaries with schizophrenia or schizoaffective disorder were followed from 1995 through 1999. Use of traditional and atypical antipsychotic medications, antidepressants, anxiolytic hypnotics, and mood stabilizers was tracked monthly. The number of medications, frequency of coprescription, and Medicaid pharmaceutical costs are described. The proportion of individuals with schizophrenia and schizoaffective disorder treated with atypical antipsychotics grew from 43 percent in 1995 to 70 percent in 1999. At the same time, concurrent use of two or more antipsychotic medications quadrupled, increasing from 5.7 percent to 24.3 percent. Persons with schizophrenia were also prescribed more antidepressants (increased from 18.5% in 1995 to 35.6% in 1999), anxiolytics (increased from 19.9% to 33.5%), and mood stabilizers (increased from 17.7% to 30.0%). The increase in multiple agent therapy appears to be broad-based. Data are needed on the effectiveness and cost-effectiveness of these practices to inform clinical decision making and health policy.
- 1 June 1999
- Published by Wiley in The Journal of Mental Health Policy and Economics
- Vol. 2 (2) , 51-54
Labor market conditions and employment of the mentally ill
- 1 June 1999
- Published by Wiley in The Journal of Mental Health Policy and Economics
- Vol. 2 (2) , 51-54
Labor market conditions and employment of the mentally ill
- 1 May 1999
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 50 (5) , 641-647
Legal System Involvement and Costs for Persons in Treatment for Severe Mental Illness and Substance Use Disorders
Persons with co-occurring severe mental illness and substance use disorders were followed for three years to better understand how they are involved with the legal system and to identify factors associated with different kinds of involvement. Data came from a three-year study of 203 persons enrolled in specialized treatment for dual disorders. Cost and utilization data were collected from multiple data sources, including police, sheriffs and deputies, officers of the court, public defenders, prosecutors, private attorneys, local and county jails, state prisons, and paid legal guardians. Over three years 169 participants (83 percent) had contact with the legal system, and 90 (44 percent) were arrested at least once. Participants were four times more likely to have encounters with the legal system that did not result in arrest than they were to be arrested. Costs associated with nonarrest encounters were significantly less than costs associated with arrests. Mean costs per person associated with an arrest were $2,295, and mean costs associated with a nonarrest encounter were $385. Combined three-year costs averaged $2,680 per person. Arrests and incarcerations declined over time. Continued substance use and unstable housing were associated with a greater likelihood of arrest. Poor treatment engagement was associated with multiple arrests. Men were more likely to be arrested, and women were more likely to be the victims of crime. Effective treatment of substance use among persons with mental illness appears to reduce arrests and incarcerations but not the frequency of nonarrest encounters. Stable housing may also reduce the likelihood and number of arrests.
- 1 May 1999
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 50 (5) , 641-647
Legal System Involvement and Costs for Persons in Treatment for Severe Mental Illness and Substance Use Disorders
Persons with co-occurring severe mental illness and substance use disorders were followed for three years to better understand how they are involved with the legal system and to identify factors associated with different kinds of involvement. Data came from a three-year study of 203 persons enrolled in specialized treatment for dual disorders. Cost and utilization data were collected from multiple data sources, including police, sheriffs and deputies, officers of the court, public defenders, prosecutors, private attorneys, local and county jails, state prisons, and paid legal guardians. Over three years 169 participants (83 percent) had contact with the legal system, and 90 (44 percent) were arrested at least once. Participants were four times more likely to have encounters with the legal system that did not result in arrest than they were to be arrested. Costs associated with nonarrest encounters were significantly less than costs associated with arrests. Mean costs per person associated with an arrest were $2,295, and mean costs associated with a nonarrest encounter were $385. Combined three-year costs averaged $2,680 per person. Arrests and incarcerations declined over time. Continued substance use and unstable housing were associated with a greater likelihood of arrest. Poor treatment engagement was associated with multiple arrests. Men were more likely to be arrested, and women were more likely to be the victims of crime. Effective treatment of substance use among persons with mental illness appears to reduce arrests and incarcerations but not the frequency of nonarrest encounters. Stable housing may also reduce the likelihood and number of arrests.
- 1 July 1998
- Published by Wiley in The Journal of Mental Health Policy and Economics
- Vol. 1 (2) , 63-71
The economic benefits of supported employment for persons with mental illness
- 1 July 1998
- Published by Wiley in The Journal of Mental Health Policy and Economics
- Vol. 1 (2) , 63-71
The economic benefits of supported employment for persons with mental illness
- 1 February 1998
- Published by Springer Nature in The Journal of Behavioral Health Services & Research
- Vol. 25 (1) , 22-34
Benefits and costs of supported employment from three perspectives
Administrators, consumers, and policy makers are increasingly interested in supported employment as a way of helping persons with severe mental illness get and keep competitive jobs. However, in an atmosphere of increased expectations for performance and declining public financing, administrators want to know the costs and benefits of different approaches before they reallocate scarce treatment or rehabilitative dollars. This article discusses the net benefits of two approaches to supported employment that were compared in a randomized trial: Individual Placement and Support (IPS) and Group Skills Training (GST). The authors analyze costs and benefits from societal, government, and consumer perspectives. Although a previous analysis showed that IPS participants were significantly more likely to find work, worked more hours, and had higher earnings, net benefits of the two programs were not significantly different. The authors also discuss some of the strengths and weaknesses of cost-benefit analysis in mental health care and suggest future directions for policy and research.
- 1 February 1998
- Published by Springer Nature in The Journal of Behavioral Health Services & Research
- Vol. 25 (1) , 22-34
Benefits and costs of supported employment from three perspectives
Administrators, consumers, and policy makers are increasingly interested in supported employment as a way of helping persons with severe mental illness get and keep competitive jobs. However, in an atmosphere of increased expectations for performance and declining public financing, administrators want to know the costs and benefits of different approaches before they reallocate scarce treatment or rehabilitative dollars. This article discusses the net benefits of two approaches to supported employment that were compared in a randomized trial: Individual Placement and Support (IPS) and Group Skills Training (GST). The authors analyze costs and benefits from societal, government, and consumer perspectives. Although a previous analysis showed that IPS participants were significantly more likely to find work, worked more hours, and had higher earnings, net benefits of the two programs were not significantly different. The authors also discuss some of the strengths and weaknesses of cost-benefit analysis in mental health care and suggest future directions for policy and research.